Home » Archive for June, 2012

Jazz Pharma (JAZZ) Wraps Up EUSA Pharma Acquisition

Jazz Pharmaceuticals (NASDAQ:JAZZ) has announced that they have wrapped up their acquisition of privately-held EUSA Pharma for $680 million in cash and notes it is accretive to their earnings and expect incremental modified EPS of $0.25 to $0.30 in 2012.  Jazz Pharma will retain the EUSA name in international business. “This transaction furthers our mission to improve patients’ lives by growing our portfolio of specialty therapies that address significant medical needs,” said Bruce Cozadd, chairman and chief executive officer... 
 
Advertisement
Advertisement
© 2006-2015 Leoncheng.